New Releases from NCBI BookshelfCrovalimab (Piasky): Indication: For the treatment of paroxysmal nocturnal hemoglobinuria (PNH) in adults and adolescents 13 years of age and older with a body weight of at least 40 kg: Reimbursement Recommendation [Internet].​Crovalimab (Piasky): Indication: For the treatment of paroxysmal nocturnal hemoglobinuria (PNH) in adults and adolescents 13 years of age and older with a body weight of at least 40 kg: Reimbursement Recommendation [Internet].